Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
0.330
-0.020 (-5.74%)
Nov 21, 2024, 2:28 PM EST - Market open

Enveric Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Market Capitalization
33429793-
Upgrade
Market Cap Growth
-18.58%-30.19%-85.19%-96.32%--
Upgrade
Enterprise Value
0-1-168795-
Upgrade
Last Close Price
0.351.302.0846.50213.00-
Upgrade
PB Ratio
0.801.540.281.31232.13-
Upgrade
P/TBV Ratio
1.091.730.302.12506.57-
Upgrade
Debt / Equity Ratio
--0.000.01--0.41
Upgrade
Quick Ratio
3.711.074.448.332.320.02
Upgrade
Current Ratio
5.171.534.618.513.350.06
Upgrade
Return on Equity (ROE)
-308.65%-197.47%-97.57%-380.82%-855.92%-
Upgrade
Return on Assets (ROA)
-96.88%-86.20%-53.92%-102.60%-166.96%-1183.53%
Upgrade
Return on Capital (ROIC)
-173.07%-116.97%-65.49%-122.09%-299.51%-
Upgrade
Earnings Yield
-315.80%-573.01%-427.30%-167.81%-0.87%-
Upgrade
FCF Yield
-261.63%-467.23%-410.17%-39.91%-0.49%-
Upgrade
Buyback Yield / Dilution
-167.86%-49.31%-206.13%-310.48%-8.82%6.45%
Upgrade
Total Shareholder Return
-167.86%-49.31%-206.13%-310.48%-8.82%6.45%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.